# Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward

> **NCT00418873** · PHASE4 · TERMINATED · sponsor: **Astellas Pharma Inc** · enrollment: 39 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Zotepine
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00418873
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** Study was stopped due to difficulty in patient enrollment
- **Last updated:** 2010-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418873, "Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00418873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*